Bringing the fundamentals into focus…
Back to MannKind Corporation
How MannKind Corporation stacks up
MNKD · against 466 other Healthcare companies of similar size
Valuation
38/ 100
Below the middle of the pack.
Ranked #293 of 467 · scores higher than 36% of peers
Bars: peers in each 10-point band of the valuation score34 peers with a valuation score of 30–39, including MNKD · Click a bar to see the companies
Why valuation scores 38?
Weighted metrics compared with all Healthcare companies.Mainly because of its earnings yield and EBITDA yield, which are weaker than most Healthcare peers.
- Negative (a loss or cash outflow), so it counts as zero whatever the share price. Earnings yield: -3.6% vs peer median 1.5%
- less operating profit (EBITDA) for the company's total value: weaker than 64% of peers. EBITDA yield: 2.2% vs peer median 4.0%
- Negative (a loss or cash outflow), so it counts as zero whatever the share price. Free cash flow yield: -1.5% vs peer median 0.0%
Metric by metric
Position: dot = MNKD, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | MNKD | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 458 reported | -3.8% | 1.5% | 30% | 30% | |
| EBITDA yieldHigher is better · 470 reported | 1.3% | 4.3% | 35% | 50% | |
| Free cash flow yieldHigher is better · 205 reported | -1.5% | -1.6% | 51% | 20% | |
| Book yieldHigher is better · 462 reported | -5.8% | 40.9% | 2% | Context only |
Ranking by valuation score
Top 5 and the companies ranked around MNKDScores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score